BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34947960)

  • 1. Low-Level Elevations of Procalcitonin Are Associated with Increased Mortality in Acute Heart Failure Patients, Independent of Concomitant Infection.
    Darche FF; Biener M; Müller-Hennessen M; Rivinius R; Stoyanov KM; Milles BR; Katus HA; Frey N; Giannitsis E
    Life (Basel); 2021 Dec; 11(12):. PubMed ID: 34947960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
    Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
    Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I.
    Hoffmann U; Espeter F; Weiß C; Ahmad-Nejad P; Lang S; Brueckmann M; Akin I; Neumaier M; Borggrefe M; Behnes M
    BMC Cardiovasc Disord; 2015 Jun; 15():50. PubMed ID: 26072112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide for Prognosis in Septic Acute Kidney Injury Patients Receiving Renal Replacement Therapy.
    Sheng X; Yang J; Yu G; Fei Y; Bao H; Yin J; Huang W; Tian Z; Wang N; Ronco C
    Blood Purif; 2019; 48(3):262-271. PubMed ID: 31311006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea.
    Alba GA; Truong QA; Gaggin HK; Gandhi PU; De Berardinis B; Magrini L; Bajwa EK; Di Somma S; Januzzi JL;
    Am J Med; 2016 Jan; 129(1):96-104.e7. PubMed ID: 26169892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Long-Term Prognostic Value of Sensitive Troponin I in Symptomatic Patients Suspected of Acute Heart Failure.
    Behnes M; Espeter F; Hoffmann U; Lang S; Brueckmann M; Akin I; Borggrefe M; Bertsch T; Weiss C; Neumaier M; Ahmad-Nejad P
    Clin Lab; 2015; 61(11):1737-47. PubMed ID: 26732000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases.
    Magrini L; Travaglino F; Marino R; Ferri E; De Berardinis B; Cardelli P; Salerno G; Di Somma S
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():133-42. PubMed ID: 23436675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18.
    Möckel M; de Boer RA; Slagman AC; von Haehling S; Schou M; Vollert JO; Wiemer JC; Ebmeyer S; Martín-Sánchez FJ; Maisel AS; Giannitsis E
    Eur J Heart Fail; 2020 Feb; 22(2):267-275. PubMed ID: 31833168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognostic value of inflammatory biomarkers for patients with acute heart failure: Construction of an inflammatory prognostic scoring system.
    Zhu X; Cheang I; Xu F; Gao R; Liao S; Yao W; Zhou Y; Zhang H; Li X
    Front Immunol; 2022; 13():1005697. PubMed ID: 36189198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of procalcitonin and critical illness score in etiological diagnosis and prognosis of sepsis caused by intra-abdominal infections].
    Yan S; Lian R; Sun L; Jin Z; Zhao C; Zhang G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jul; 33(7):792-797. PubMed ID: 34412746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
    Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
    Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of procalcitonin on predicting the severity and prognosis in patients with early ARDS: a prospective observation study].
    Yu Z; Ji M; Hu X; Yan J; Jin Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):34-38. PubMed ID: 28459401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prediction value of plasma histone in prognosis of sepsis patients].
    Lu N; Jiang L; Zhu B; Yang D; Zheng R; Shao J; Xi X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jun; 31(6):674-679. PubMed ID: 31315721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the IMPACT EU-trial: improve management of heart failure with procalcitonin biomarkers in cardiology (BIC)-18.
    Möckel M; Slagman A; Vollert JO; Ebmeyer S; Wiemer JC; Searle J; Giannitsis E; Kellum JA; Maisel A
    Biomarkers; 2018 Feb; 23(1):97-103. PubMed ID: 29264937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A; Neath SX; Landsberg J; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Möckel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Christenson RH; Potocki M; McCord J; Terracciano G; Hartmann O; Bergmann A; Morgenthaler NG; Anker SD
    Eur J Heart Fail; 2012 Mar; 14(3):278-86. PubMed ID: 22302662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are admission procalcitonin levels universal mortality predictors across different medical emergency patient populations? Results from the multi-national, prospective, observational TRIAGE study.
    Sager R; Wirz Y; Amin D; Amin A; Hausfater P; Huber A; Haubitz S; Kutz A; Mueller B; Schuetz P
    Clin Chem Lab Med; 2017 Oct; 55(12):1873-1880. PubMed ID: 28412721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
    Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
    Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
    Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
    Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure.
    Xiao J; Gao R; Bei Y; Zhou Q; Zhou Y; Zhang H; Jin M; Wei S; Wang K; Xu X; Yao W; Xu D; Zhou F; Jiang J; Li X; Das S
    Cell Physiol Biochem; 2017; 41(3):865-874. PubMed ID: 28214846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Serum Cysteine-Rich Protein 61 in Patients with Acute Heart Failure.
    Zhao J; Zhang C; Liu J; Zhang L; Cao Y; Wu D; Yao F; Xue R; Huang H; Jiang J; Dong B; Sun Y; Bai Y; Dong Y; Liu C
    Cell Physiol Biochem; 2018; 48(3):1177-1187. PubMed ID: 30045012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.